Nurix Therapeutics, Inc. (NRIX) ownership: Top institutional holder: BlackRock, Inc. ($138.35M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 8925642.00 | $138.35M | 2026-03-31 |
| Redmile Group, LLC | 7732808.00 | $119.86M | 2026-03-31 |
| VANGUARD GROUP INC | 5949512.00 | $112.86M | 2025-12-31 |
| Vestal Point Capital, LP | 6500000.00 | $100.75M | 2026-03-31 |
| Deep Track Capital, LP | 6345244.00 | $98.35M | 2026-03-31 |
| FMR LLC | 5541271.00 | $85.89M | 2026-03-31 |
| STATE STREET CORP | 5141195.00 | $79.69M | 2026-03-31 |
| MORGAN STANLEY | 4931999.00 | $76.45M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 |
Back to NRIX overview · NRIX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.